“A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT/QTc Intervals in Adult Healthy Volunteers”, J of Skin, vol. 4, no. 6, p. s109, Oct. 2020, doi: 10.25251/skin.4.supp.109.